The finding that both tumor RAGE and CLRs interact with Hspg2/Nidogen-1, suggests that Hspg2/Nidogen-1 might bridge between RAGE and CLRs, and thus strengthen the neutrophil-tumor cell synapse. Here, LARS1 is linked to neoplasm.